Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 USD | -1.23% | -6.09% | +47.36% |
14/05 | Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
30/04 | North American Morning Briefing : More Earnings -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.36% | 224M | |
+51.85% | 57.87B | |
+41.65% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ACRV Stock
- News Acrivon Therapeutics, Inc.
- JMP Securities Starts Acrivon Therapeutics With Market Outperform Rating, $14 Price Target